Table 2 Mains results for transparency indicators for the 101 trials in our study
Number (N) | N/101 (%) | |
|---|---|---|
Access to trial documentation | ||
Available protocol | 34 | 34 |
Access in publication | 20 | 20 |
Access in registry | 8 | 8 |
Both access | 6 | 6 |
Available statistical analysis plan | 32 | 32 |
Data sharing | ||
Willing to share | 25 | 25 |
Statement in publication | 19 | 19 |
Statement in the registry | 5 | 5 |
Statement in both publication and registry | 1 | 1 |
Not willing to share | 25 | 25 |
No statement on data sharing | 51 | 50 |
Completeness of reporting | ||
Complete reporting of all items | 5 | 5 |
Partial reporting of all items | 96 | 95 |
Reporting of primary outcome(s) measure(s) | ||
Complete | 74 | 73 |
Partial | 27 | 27 |
Reporting of randomization and allocation concealment | ||
Generation of the allocation sequence | 73 | 72 |
Allocation concealment | 53 | 52 |
Reporting of blinding | ||
Status unclear | 7 | 6 |
Unblinded trials | 47 | 47 |
Blinded trials | 47 | 47 |
Reporting of participant flow | ||
Available flow chart | 94 | 93 |
Complete | 81 | 80 |
Partial | 19 | 19 |
Not reported | 1 | 1 |
Reporting of results for the primary outcome(s) | ||
Complete | 55 | 53 |
Partial | 42 | 42 |
Not reported | 4 | 5 |
Reporting of harms | ||
Complete | 13 | 13 |
Partial | 49 | 48 |
Not reported | 39 | 39 |
Reporting of registration number | 90 | 89 |